V023-1030 Screening compound: 3-{[5-(2H-1,3-benzodioxol-5-yloxy)-2-(4-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}-N-benzylbenzamide

V023-1030 Screening compound: 3-{[5-(2H-1,3-benzodioxol-5-yloxy)-2-(4-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}-N-benzylbenzamide
V023-1030 Screening compound: 3-{[5-(2H-1,3-benzodioxol-5-yloxy)-2-(4-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}-N-benzylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-1030
3-{[5-(2H-1,3-benzodioxol-5-yloxy)-2-(4-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}-N-benzylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-1030

Molecular Formula

C32H26N4O5 (C32 H26 N4 O5)

Compound Name

3-{[5-(2H-1,3-benzodioxol-5-yloxy)-2-(4-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}-N-benzylbenzamide

IUPAC name

3-{[5-(2H-13-benzodioxol-5-yloxy)-2-(4-methylphenyl)-3-oxo-23-dihydropyridazin-4-yl]amino}-N-benzylbenzamide

SMILES

Cc(cc1)ccc1N(C1=O)N=CC(Oc(cc2)cc3c2OCO3)=C1Nc1cc(C(NCc2ccccc2)=O)ccc1

InChI

InChI=1S/C32H26N4O5/c1-21-10-12-25(13-11-21)36-32(38)30(29(19-34-36)41-26-14-15-27-28(17-26)40-20-39-27)35-24-9-5-8-23(16-24)31(37)33-18-22-6-3-2-4-7-22/h2-17,19,35H,18,20H2,1H3,(H,33,37)

InChI Key

HEHGRCDTXOYFIV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19831622

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

546.58

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.311

Distribution Coefficient, logD

5.280

Water Solubility, LogSw

-5.38

Polar Surface Area

84.845

Acid Dissociation Constant (pKa)

11.18

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.40

V023-1030 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with V023-1030 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-1030?
Check Price and Availability of V023-1030, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-1030 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-1030
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-1030
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-1030 available by request